LCCAX | VTSMX | LCCAX / VTSMX | |
Total Expense Ratio | 0.99 | 0.14 | 707% |
Annual Report Gross Expense Ratio | 0.99 | 0.14 | 707% |
Fund Existence | 27 years | 33 years | - |
Gain YTD | -4.804 | -4.660 | 103% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.7B | 1.72T | 1% |
Annual Yield % from dividends | 0.33 | 1.26 | 27% |
Returns for 1 year | -2.45 | 7.85 | -31% |
Returns for 3 years | 20.76 | 39.37 | 53% |
Returns for 5 years | 34.99 | 87.92 | 40% |
Returns for 10 years | 53.22 | 162.78 | 33% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 20.28 | 0.16 | +0.80% |
ProShares UltraShort Nasdaq Biotech | |||
QCON | 45.82 | 0.33 | +0.73% |
American Century Quality Cnvtbl Scts ETF | |||
EAD | 6.74 | 0.02 | +0.30% |
Allspring Income Opportunities Fund | |||
SIVR | 30.87 | -0.05 | -0.16% |
abrdn Physical Silver Shares ETF | |||
GBF | 102.95 | -0.48 | -0.46% |
iShares Government/Credit Bond ETF |